Fedratinib
CAS 936091-26-8Small Molecule
Overview
Fedratinib is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1287853).
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Fedratinib expires 24 Sept 2039 and exclusivity 16 Aug 2026. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- N-tert-butyl-3-[[5-methyl-2-[4-(2-pyrrolidin-1-ylethoxy)anilino]pyrimidin-4-yl]amino]benzenesulfonamide
- Canonical SMILES
- CC1=CN=C(N=C1NC2=CC(=CC=C2)S(=O)(=O)NC(C)(C)C)NC3=CC=C(C=C3)OCCN4CCCC4
- InChIKey
- JOOXLOJCABQBSG-UHFFFAOYSA-N
Verified Supplier Partner
Do you supply Fedratinib? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.